Last reviewed · How we verify
ISIS-GCGRRx
At a glance
| Generic name | ISIS-GCGRRx |
|---|---|
| Also known as | ISIS 449884 |
| Sponsor | Ionis Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes (PHASE2)
- Study to Evaluate the Effect of ISIS GCGRRx on Hepatic Lipid and Glycogen Content in Type 2 Diabetes (PHASE2)
- Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |